While the WHO last week recommended that antiviral remdesivir not be
used for severely ill Covid-19 patients, Mumbai doctors published the
first scientific study showing another antiviral, favipiravir, reduced
the "cure time" in mild cases.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-19-favipiravir-shows-hope-in-mumbai-trial/articleshow/79363011.cms
No comments:
Post a Comment